ALLMED SOLUTIONS LTD |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 39 ILa | -3.70% |
|
-6.02% | +4.84% |
| Mar. 07 | Allmed Solutions Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Feb. 05 | Allmed Solutions Ltd announces an Equity Buyback for $1.5 million worth of its shares. | CI |
| Sales 2022 | - | Sales 2023 | - | Capitalization | 40.22M 10.6M 4.02B |
|---|---|---|---|---|---|
| Net income 2022 | -12M -3.16M -1.2B | Net income 2023 | 1M 264K 100M | EV / Sales 2022 | - |
| Net cash position 2022 | 20.36M 5.37M 2.04B | Net cash position 2023 | 56.23M 14.82M 5.62B | EV / Sales 2023 | - |
| P/E ratio 2022 |
-1.78
x | P/E ratio 2023 |
28.3
x | Employees | 19 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 64.33% |
More Fundamentals
* Assessed data
More news
| 1 day | -3.70% | ||
| 1 week | -6.02% | ||
| Current month | -10.14% | ||
| 1 month | -8.67% | ||
| 3 months | -2.26% | ||
| 6 months | +20.37% | ||
| Current year | +4.84% |
1 week
38.60
42.20
1 month
38.6044.70
Current year
36.5047.50
1 year
28.0047.50
3 years
24.2094.90
5 years
24.2094.90
10 years
24.20324.70
| Managers | Title | Age | Since |
|---|---|---|---|
Oz Moshe Shapira
CEO | Chief Executive Officer | 68 | 22-02-28 |
Asaf Alperovitz
BRD | Director/Board Member | 54 | 12-09-30 |
Mor Salomon Liss
AUD | Comptroller/Controller/Auditor | 38 | 21-10-16 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
David Milch
FOU | Founder | 68 | 04-01-03 |
Asaf Alperovitz
BRD | Director/Board Member | 54 | 12-09-30 |
| Director/Board Member | 55 | 22-08-02 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-25 | 39 | -3.70% | 13 400 |
| 24-04-24 | 40.5 | -2.41% | 22,017 |
| 24-04-18 | 41.5 | -1.66% | 60,476 |
| 24-04-17 | 42.2 | -1.40% | 5,439 |
| 24-04-16 | 42.8 | +2.64% | 150,000 |
Delayed Quote TEL AVIV STOCK EXCHANGE, April 25, 2024 at 07:24 am EDT
More quotes
Allmed Solutions Ltd, former Allium Medical Solutions Ltd, is an Israel-based company, which develops, manufactures and markets minimally invasive products internationally. Its products are used by physicians to treat a number of diseases and patients worldwide. The Company's product lines include: Covered Stents, which offers Ureteral Stent (URS), Round Posterior Stent (RPS), Triangular Prostatic Stent (TPS), Bulbar Stent (BUS) and Biliary Stent (BIS); Uro-Gynecology, which offers EndoFast Reliant System, EndoFast Resorb, EndoFast Reliant MN and EndoFast Reliant SCP; Type II Diabetes, which offers the Gastro-duodenal sleeve (GDS), as well as Cardiovascular, which offers WIRION EPD System. The Company's products serve patients with the following medical conditions: Pelvic Organ Prolapse (POP), Sacrocolpopexy, Male Stress Urinary Incontinence (SUI), Urethral/Ureteral Stricture, Carotid Stenosis, Biliary Stricture and Type II Diabetes.
| 1st Jan change | Capi. | |
|---|---|---|
| +4.84% | 10.43M | |
| +12.49% | 128B | |
| -9.24% | 10.66B | |
| -2.20% | 8.55B | |
| +15.12% | 7.1B | |
| +26.97% | 5.06B | |
| +7.09% | 3.4B | |
| +0.27% | 3.08B | |
| -10.28% | 2.11B | |
| -8.61% | 2.03B |
- Stock Market
- Equities
- ALMD Stock
